113 related articles for article (PubMed ID: 20797733)
1. Safety and outcome after thrombolytic treatment in ischemic stroke patients with high-risk cardioembolic sources and prior subtherapeutic warfarin use.
Kim YD; Lee JH; Jung YH; Choi HY; Nam CM; Yang JH; Cho HJ; Nam HS; Lee KY; Heo JH
J Neurol Sci; 2010 Nov; 298(1-2):101-5. PubMed ID: 20797733
[TBL] [Abstract][Full Text] [Related]
2. Subtherapeutic international normalized ratio in warfarin-treated patients increases the risk for symptomatic intracerebral hemorrhage after intravenous thrombolysis.
Seet RC; Zhang Y; Moore SA; Wijdicks EF; Rabinstein AA
Stroke; 2011 Aug; 42(8):2333-5. PubMed ID: 21659639
[TBL] [Abstract][Full Text] [Related]
3. Intravenous thrombolysis in posterior cerebral artery infarctions.
Breuer L; Huttner HB; Jentsch K; Blinzler C; Winder K; Engelhorn T; Köhrmann M
Cerebrovasc Dis; 2011; 31(5):448-54. PubMed ID: 21346350
[TBL] [Abstract][Full Text] [Related]
4. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
Prabhakaran S; Rivolta J; Vieira JR; Rincon F; Stillman J; Marshall RS; Chong JY
Arch Neurol; 2010 May; 67(5):559-63. PubMed ID: 20212195
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
7. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
8. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
9. Thrombolysis in ischemic stroke patients with prior subtherapeutic warfarin use.
Tai ML; Sharma VK
J Neurol Sci; 2011 Jan; 300(1-2):194-5; author reply 195-6. PubMed ID: 21084101
[No Abstract] [Full Text] [Related]
10. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
11. Admission international normalized ratio and acute infarct volume in ischemic stroke.
Ay H; Arsava EM; Gungor L; Greer D; Singhal AB; Furie KL; Koroshetz WJ; Sorensen AG
Ann Neurol; 2008 Nov; 64(5):499-506. PubMed ID: 18661516
[TBL] [Abstract][Full Text] [Related]
12. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
Lopes RD; Alexander JH; Al-Khatib SM; Ansell J; Diaz R; Easton JD; Gersh BJ; Granger CB; Hanna M; Horowitz J; Hylek EM; McMurray JJ; Verheugt FW; Wallentin L;
Am Heart J; 2010 Mar; 159(3):331-9. PubMed ID: 20211292
[TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
14. Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.
Vergouwen MD; Casaubon LK; Swartz RH; Fang J; Stamplecoski M; Kapral MK; Silver FL;
Stroke; 2011 Apr; 42(4):1041-5. PubMed ID: 21350204
[TBL] [Abstract][Full Text] [Related]
15. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
16. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
17. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
18. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
19. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
[TBL] [Abstract][Full Text] [Related]
20. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Kasner SE; Benesch CG; Sila CA; Jovin TG; Romano JG;
N Engl J Med; 2005 Mar; 352(13):1305-16. PubMed ID: 15800226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
